News releases from Science 37
Science 37® Appoints Christine Pellizzari as Chief Legal Officer
September 01, 2021
Science 37 announces the addition of Christine Pellizzari to the senior executive team as Chief Legal Officer.
New Science 37® Report: Nearly 100% of Biopharma Executives Expect Clinical Trial Decentralization to Increase Yet Lack Internal Capabilities to Operationalize
June 24, 2021
Science 37 released the DCT OS Report highlighting the growing trend of decentralization in research and the implementation challenges faced by firms.
Join Science 37 for a Panel of Health Industry Leaders Exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience” at Reuters Webinar
June 23, 2021
Science 37 CEO to participate in Reuters Webinar exploring “Decentralized Clinical Trials and the Empowered Patient Trial Experience”
Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
March 11, 2021
Using Science 37's decentralized clinical trial model, the partnership offers Xperiome's research-ready, rare disease patients more study opportunities with less burden.
With a presence in Europe, Asia-Pacific, and the Middle East, Medgate extends the Science 37 Decentralized Clinical Trial Operating System--enabling more provider and patient research participation.
Science 37® Launches 'Science 37 Certified'--a Partnership Program Enabling CROs to Effectively Execute Decentralized Clinical Trials
January 21, 2021
Science 37's flexible Science 37 Certified program provides contract research organizations (CROs) with direct access to its Operating System to enable decentralized trial solutions.
Science 37® and Signant Health Partner to Expand Access to CNS Research with Decentralized Clinical Trials
October 15, 2020
Collaboration enables patients to participate in clinical trials from their homes--broadening patient access and enrollment while strengthening the service offerings across a variety of CNS...
Science 37® Launches Integrated Electronic Health Records into Its Industry-Leading Decentralized Clinical Trial Technology Platform
September 10, 2020
Patients using Science 37's technology platform can now connect their health record directly, in real time--eliminating paper documentation and streamlining information sharing
John Hubbard, Ph.D., Joins Science 37® Board of Directors
September 02, 2020
Science 37, the industry leader in decentralized clinical trials, today announced the appointment of industry veteran John Hubbard, Ph.D., FCP to its Board of Directors.
Technology partnership enables trial sponsors to improve imaging, respiratory, and cardiac safety data quality while reducing patient burden and risk.
Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market
August 20, 2020
In a significantly oversubscribed offering, Science 37 attracted capital to support its rapid growth, expand its technology platform and accelerate global expansion.
Science 37 adds to its industry-leading virtual trial capabilities in Europe, South America, and Asia-Pacific
Executive role applies financial rigor to ensure profitable growth as the company continues to scale
The partnership combines artificial intelligence with comprehensive virtual trial services to bring novel insights to research
The partnership addresses key concerns for clinical trial sponsors as they transition to virtual trials in light of the COVID-19 pandemic
The new partnership will help accelerate the start-up time for clinical trials related to the COVID-19 pandemic
The report explores approaches for sponsors to mitigate risks to patient safety and business continuity in clinical trials--both immediately and moving forward
Science 37® Strengthens Operational Efficiencies with EDC Integration
February 18, 2020
Science 37® Enhances Its Patient Experience and Introduces Native Support for iOS and Android
February 13, 2020
Its enhanced patient workflow and native smartphone support make patient participation simpler than ever.
Science 37® Extends Market-Leading Capabilities in Decentralized Clinical Trial Execution
January 14, 2020
New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies
Science 37® Appoints Steven Geffon as Chief Commercial Officer
December 17, 2019
Executive role will significantly scale commercial operations and create unparalleled value for clients
Science 37® Names David Coman Chief Executive Officer
November 21, 2019
Keck School of Medicine of USC and Science 37® Collaborate on Largest Ever NIH-Funded, Telemedicine-Based Dermatology Study
October 01, 2019
Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies
January 03, 2019
Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running...
Science 37 Welcomes Judy Smythe as Chief Operating Officer, Bardia Akbari as Senior Vice President of Clinical Operations, and Niv Caviar as Chief Financial Officer
October 02, 2018
Science 37 Welcomes Judy Smythe as COO, Bardia Akbari as Senior VP of Clinical Operations, and Niv Caviar as CFO.
Science 37 Partners with UCB to Fundamentally Change the Clinical Trial Ecosystem, Focusing on More Patient-Friendly, Technology-Enabled Trials at Home
May 03, 2018
Science 37, a trailblazing company focused on “site-less” clinical trials, announced today a strategic collaboration with global pharmaceutical leader, UCB, to improve the clinical trial experience....
Science 37 and VisualDx Partner to Provide a More Patient-First Approach to Decentralized Clinical Research in Dermatology
April 24, 2018
Healthcare Informatics Company with Proven Products to Enhance Diagnosis Will Partner with End-to-End DCT Platform
Science 37 and Novartis Sign Strategic Alliance to Advance Decentralized Clinical Trials
March 06, 2018
Science 37, a trailblazing company focused on “site-less” clinical trials, announced today a strategic alliance with Novartis that will support the development of its new decentralized clinical trial...
Science 37 and Otsuka Pharmaceutical Collaborate to Advance Digital Health Innovation with Focus on Technology-Enabled Clinical Trials at Home
December 05, 2017
Science 37, a trailblazing company focused on “site-less” clinical trials, and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), announce today a strategic collaboration to support...
Science 37 and AOBiome Complete Industry-First Virtual Clinical Trial Through Metasite™ (Decentralized) Operating Model
October 24, 2017
Trailblazing company focused on “site-less” clinical trials, Science 37, completes first-ever virtual dermatology research study in record time.